APOTHEEK HERBOTS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK HERBOTS
Largest movements
- Cash +€279,674
up €279,674 (+186.9%), from €149,659 to €429,333
mainly Net result for the year (+€267,456) and Other debts (+€150,998)
- Current investments -€50,000
down €50,000 (-14.3%), from €350,000 to €300,000
- Tangible fixed assets +€40,745
up €40,745 (+45.8%), from €88,915 to €129,659
of which Furniture and vehicles: +€45,836
- Other debts +€150,998
up €150,998 (+195.7%), from €77,164 to €228,162
- Reserves +€83,031
up €83,031 (+7.3%), from €1.1m to €1.2m
of which Distributable reserves: +€83,031
- Trade debts +€35,441
up €35,441 (+14.1%), from €251,475 to €286,915
- Gross operating margin -€48,923
down €48,923 (-7.5%), from €653,220 to €604,296
- Staff costs -€33,960
down €33,960 (-15.9%), from €214,005 to €180,045
- Depreciation +€12,751
up €12,751 (+116.2%), from €10,969 to €23,720
- Taxes -€10,668
down €10,668 (-7.9%), from €134,559 to €123,891
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,652,791 | €1,915,085 | +€262,294 | +15.9% |
| Fixed assets | 21/28 | €93,915 | €134,659 | +€40,745 | +43.4% |
| Tangible fixed assets | 22/27 | €88,915 | €129,659 | +€40,745 | +45.8% |
| Land and buildings | 22 | €2,007 | €1,429 | -€578 | -28.8% |
| Plant, machinery and equipment | 23 | €23,783 | €19,270 | -€4,513 | -19.0% |
| Furniture and vehicles | 24 | €63,124 | €108,961 | +€45,836 | +72.6% |
| Financial fixed assets | 28 | €5,000 | €5,000 | = | 0.0% |
| Current assets | 29/58 | €1,558,876 | €1,780,426 | +€221,549 | +14.2% |
| Amounts receivable after more than one year | 29 | €366,000 | €366,000 | = | 0.0% |
| Trade receivables | 290 | €0 | - | = | |
| Other amounts receivable | 291 | €366,000 | €366,000 | = | 0.0% |
| Stocks and contracts in progress | 3 | €231,860 | €238,858 | +€6,998 | +3.0% |
| Stocks | 30/36 | €231,860 | €238,858 | +€6,998 | +3.0% |
| Amounts receivable within one year | 40/41 | €453,056 | €434,570 | -€18,486 | -4.1% |
| Trade receivables | 40 | €295,771 | €299,904 | +€4,133 | +1.4% |
| Other amounts receivable | 41 | €157,285 | €134,666 | -€22,619 | -14.4% |
| Current investments | 50/53 | €350,000 | €300,000 | -€50,000 | -14.3% |
| Cash at bank and in hand | 54/58 | €149,659 | €429,333 | +€279,674 | +186.9% |
| Deferred charges and accrued income | 490/1 | €8,302 | €11,665 | +€3,364 | +40.5% |
| Total equity and liabilities | 10/49 | €1,652,791 | €1,915,085 | +€262,294 | +15.9% |
| Equity | 10/15 | €1,212,142 | €1,295,173 | +€83,031 | +6.8% |
| Contributions | 10/11 | €81,100 | €81,100 | = | 0.0% |
| Reserves | 13 | €1,131,042 | €1,214,073 | +€83,031 | +7.3% |
| Non-distributable reserves | 130/1 | €8,730 | €8,730 | = | 0.0% |
| Reserves not available under the articles | 1311 | €8,730 | €8,730 | = | 0.0% |
| Distributable reserves | 133 | €1,122,312 | €1,205,343 | +€83,031 | +7.4% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €440,649 | €619,912 | +€179,263 | +40.7% |
| Amounts payable within one year | 42/48 | €440,649 | €619,912 | +€179,263 | +40.7% |
| Financial debts | 43 | €10,000 | €10,188 | +€188 | +1.9% |
| Credit institutions | 430/8 | €10,000 | €10,188 | +€188 | +1.9% |
| Trade debts | 44 | €251,475 | €286,915 | +€35,441 | +14.1% |
| Suppliers | 440/4 | €251,475 | €286,915 | +€35,441 | +14.1% |
| Advances received on contracts in progress | 46 | €4,092 | €9,865 | +€5,773 | +141.1% |
| Taxes, remuneration and social security | 45 | €97,918 | €84,781 | -€13,137 | -13.4% |
| Taxes | 450/3 | €78,157 | €64,583 | -€13,574 | -17.4% |
| Remuneration and social security | 454/9 | €19,761 | €20,198 | +€437 | +2.2% |
| Other amounts payable | 47/48 | €77,164 | €228,162 | +€150,998 | +195.7% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Non-recurring operating income | 76A | €14,000 | €0 | -€14,000 | -100.0% |
| Remuneration, social security and pensions | 62 | €214,005 | €180,045 | -€33,960 | -15.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,969 | €23,720 | +€12,751 | +116.2% |
| Other operating charges | 640/8 | €4,769 | €8,518 | +€3,748 | +78.6% |
| Gross operating margin | 9900 | €653,220 | €604,296 | -€48,923 | -7.5% |
| Operating profit (loss) | 9901 | €423,476 | €392,014 | -€31,463 | -7.4% |
| Financial income | 75/76B | €4,197 | €3,779 | -€418 | -10.0% |
| Recurring financial income | 75 | €4,197 | €3,779 | -€418 | -10.0% |
| Financial charges | 65/66B | €3,682 | €4,445 | +€763 | +20.7% |
| Recurring financial charges | 65 | €3,682 | €4,445 | +€763 | +20.7% |
| Profit (loss) for the period before taxes | 9903 | €423,992 | €391,348 | -€32,644 | -7.7% |
| Income taxes | 67/77 | €134,559 | €123,891 | -€10,668 | -7.9% |
| Profit (loss) for the period | 9904 | €289,432 | €267,456 | -€21,976 | -7.6% |
| Profit (loss) for the period to be appropriated | 9905 | €289,432 | €267,456 | -€21,976 | -7.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.